U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Medical Officer
  6. Office of Combination Products
  1. Office of the Chief Medical Officer

Office of Combination Products Also referred to as: OCP

Who We Are

The Office of Combination Products (OCP) assigns combination products to the FDA’s medical product centers for review, helps coordinate timely, effective and aligned reviews of combination products and oversees the postmarket activities of combination products to help ensure their safety and quality in order to protect patients from harm.

What We Do

  • Serve as primary point of contact for combination product issues for FDA staff and industry.
  • Develop guidance, regulations and standard operating procedures to clarify combination product regulation.
  • Classify products as drugs, devices, biological products or combination products and assign an FDA center for premarket review and postmarket safety oversight. 
  • Ensure timely and effective review of combination products by overseeing and coordinating reviews involving more than one FDA center.
  • Oversee postmarket safety to protect patients from potential health risks associated with combination products currently on the market.
  • Facilitate dispute resolution regarding the timeliness of premarket review of combination products.
  • Update agreements, guidance documents or practices specific to assigning combination products.
  • Develop annual reports to Congress on the office’s activities and impacts.
  • Provide training to FDA staff and regulated industry on combination product regulation.

Contact Us

Email: combination@fda.gov
Phone: 301-796-8930
Fax: 301-847-8619

Office of Combination Products
Office of the Chief Medical Officer
Food and Drug Administration
10903 New Hampshire Ave. WO-32, Room 5129
Silver Spring, MD 20993

Resources



Back to Top